Selective COX-2 inhibitors, NSAIDs, aspirin, myocardial infarction

被引：36

作者：

Dalen, JE

机构：

来源：

ARCHIVES OF INTERNAL MEDICINE | 2002年 / 162卷 / 10期

关键词：

D O I：

10.1001/archinte.162.10.1091

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1091 / 1092

页数：2

共 13 条

[1] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
ALTMAN, R
CARRERAS, L
DIAZ, R
FIGUEROA, E
PAOLASSO, E
PARODI, JC
CADE, JF
DONNAN, G
EADIE, MJ
GAVAGHAN, TP
OSULLIVAN, EF
PARKIN, D
RENNY, JTG
SILAGY, C
VINAZZER, H
ZEKERT, F
ADRIAENSEN, H
BERTRANDHARDY, JM
BRAN, M
DAVID, JL
DRICOT, J
LAVENNEPARDONGE, E
LIMET, R
LOWENTHAL, A
MORIAU, M
SCHAPIRA, S
SMETS, P
SYMOENS, J
VERHAEGHE, R
VERSTRAETE, M
ATALLAH, A
BARNETT, H
BATISTA, R
BLAKELY, J
CAIRNS, JA
COTE, R
CROUCH, J
EVANS, G
FINDLAY, JM
GENT, M
LANGLOIS, Y
LECLERC, J
NORRIS, J
PINEO, GF
POWERS, PJ
ROBERTS, R
SCHWARTZ, L
SICURELLA, J
TAYLOR, W
THEROUX, P
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921): : 81 - 100
[2] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
Bombardier, C
Laine, L
Reicin, A
Shapiro, D
Burgos-Vargas, R
Davis, B
Day, R
Ferraz, MB
Hawkey, CJ
Hochberg, MC
Kvien, TK
Schnitzer, TJ
Weaver, A
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) : 1520 - 1528
[3] Antithrombotic agents in coronary artery disease
Cairns, JA
Théroux, P
Lewis, HD
Ezekowitz, M
Meade, TW
[J]. CHEST, 2001, 119 (01) : 228S - 252S
[4] AN APPLE A DAY OR AN ASPIRIN A DAY
DALEN, JE
[J]. ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (06) : 1066 - 1069
[5] An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease
Hebert, PR
Hennekens, CH
[J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (20) : 3123 - 3127
[6] Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib
Konstam, MA
Weir, MR
Reicin, A
Shapiro, D
Sperling, RS
Barr, E
Gertz, BJ
[J]. CIRCULATION, 2001, 104 (19) : 2280 - 2288
[7] Risk of cardiovascular events associated with selective COX-2 inhibitors
Mukherjee, D
Nissen, SE
Topol, EJ
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (08): : 954 - 959
[8] Association between naproxen use and protection against acute myocardial infarction
Rahme, E
Pilote, L
LeLorier, J
[J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (10) : 1111 - 1115
[9] Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials
Sanmuganathan, PS
Ghahramani, P
Jackson, PR
Wallis, EJ
Ramsay, LE
[J]. HEART, 2001, 85 (03) : 265 - 271
[10] Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial
Silverstein, FE
Faich, G
Goldstein, JL
Simon, LS
Pincus, T
Whelton, A
Makuch, R
Eisen, G
Agarwal, NM
Stenson, WF
Burr, AM
Zhao, WW
Kent, JD
Lefkowith, JB
Verburg, KM
Geis, GS
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (10): : 1247 - 1255

← 1 2 →